Gabapentin is not a federally controlled substance in the United States. The Drug Enforcement Administration does not schedule it, and at the national level it can be prescribed without the extra restrictions that apply to drugs like opioids or benzodiazepines. But a growing number of states have independently classified it as a Schedule V controlled substance, and many more require pharmacies to report every gabapentin prescription to a monitoring database. That patchwork of state laws is why your experience filling a gabapentin prescription can feel very different depending on where you live.
Federal vs. State Classification
At the federal level, gabapentin sits outside the Controlled Substances Act entirely. A comprehensive review of laws across all 51 U.S. jurisdictions (50 states plus Washington, D.C.) from 2016 through 2024 found that eight jurisdictions, about 16%, have classified gabapentin as a Schedule V controlled substance on their own. Schedule V is the lowest tier, the same category as cough syrups containing small amounts of codeine. In those states, prescriptions carry tighter rules: limits on refills, requirements for a new prescription after a set period, and mandatory reporting to the state’s prescription drug monitoring program.
Another 17 jurisdictions, about 33%, took a middle path. They require pharmacies to log gabapentin prescriptions in their monitoring databases but stop short of formally scheduling the drug. That means roughly half of all U.S. jurisdictions now track gabapentin prescribing in some way, even though the federal government does not require it.
Why States Started Restricting It
The push to regulate gabapentin grew out of two overlapping concerns: people were using it recreationally, and it was showing up alongside opioids in overdose cases. Gabapentin can produce feelings of euphoria and relaxation, particularly at high doses, and those effects made it attractive for misuse. Qualitative research with people who misuse gabapentin found that a common motive was simply getting high, while serious harms like dissociation, loss of consciousness, and overdose typically occurred when gabapentin was combined with other substances.
The opioid crisis amplified these concerns. When gabapentin is taken alongside opioids, it increases the risk of dangerous breathing problems. A large study of Medicare patients with spine conditions found that people taking gabapentin plus an opioid had a 19% higher rate of respiratory events compared to those taking a different non-opioid pain medication with their opioid. Respiratory failure occurred in 2.3% of the gabapentin-plus-opioid group versus 1.8% in the comparison group. Those numbers may sound small, but scaled across millions of prescriptions they represent thousands of additional hospitalizations.
The 2019 FDA Warning
In 2019, the FDA required new warnings on gabapentin labels about the risk of serious breathing difficulties. The agency specifically flagged patients who also take opioids or other drugs that slow the central nervous system, people with lung conditions like COPD, and elderly patients. The FDA also ordered manufacturers to conduct clinical trials evaluating gabapentin’s abuse potential, particularly in combination with opioids, citing rising rates of co-use.
That same year, the United Kingdom went further. On April 1, 2019, the UK reclassified gabapentin as a Class C controlled drug under the Misuse of Drugs Act, based on a recommendation from its Advisory Council on the Misuse of Drugs. The council cited increasing reports of misuse, a risk of addiction, and potential for illegal diversion. The UK’s decision influenced how other countries and U.S. states thought about the drug’s risk profile.
How Gabapentin Actually Works
Gabapentin’s name suggests it acts on GABA, the brain’s main calming chemical, and it was originally designed as a GABA look-alike. But research has shown it has no effect on GABA receptors or the transporters that move GABA around the brain. Instead, it works by binding to a specific part of voltage-gated calcium channels in nerve cells. These channels help control how much signaling activity neurons produce. When gabapentin binds to them, it reduces the number of these channels that reach the cell surface, which dials down excessive nerve firing.
This effect takes time. In lab studies, gabapentin applied for just a few minutes or even several hours had no measurable impact on calcium channel activity. Only with sustained, chronic exposure did it reduce nerve signaling. That slow onset helps explain why gabapentin works for conditions like nerve pain and epilepsy, where overactive nerve signaling builds gradually, but it also means the drug accumulates in the body in ways that can create physical dependence over weeks or months of use.
Physical Dependence and Withdrawal
Gabapentin can produce real physical dependence even at prescribed doses. Withdrawal symptoms can begin anywhere from 12 hours to 7 days after stopping the drug and commonly include anxiety, restlessness, body pain, sweating, headaches, nausea, dizziness, confusion, and insomnia. Most withdrawal episodes last 5 to 10 days, but some people require up to 18 weeks to fully taper off while managing symptoms.
Less common but more serious withdrawal effects include seizures, heart palpitations, high blood pressure, and depressed mood. The seizure risk is particularly notable because many people take gabapentin to prevent seizures in the first place, and abruptly stopping can trigger rebound episodes that are worse than the original condition. This is one reason doctors taper the dose gradually rather than stopping it all at once, and it is one of the practical reasons states began treating gabapentin more like a controlled substance: tracking prescriptions helps identify patients who might be at risk of sudden discontinuation if they’re getting pills from multiple sources.
What This Means for Your Prescription
If you live in a state that schedules gabapentin, your pharmacy will log each prescription in a monitoring database, and your doctor may check that database before writing a refill. You may face limits on how many refills you can get without a new office visit. Transferring prescriptions between pharmacies can also be more complicated for scheduled drugs.
In states that require monitoring but don’t formally schedule gabapentin, the practical difference is smaller. Your prescription still gets logged, but refill rules are generally less restrictive. And in states with no gabapentin-specific policies, you’ll fill it like any other non-controlled prescription, though your pharmacist may still flag combinations with opioids or other sedating medications based on the FDA’s 2019 warnings.